Mrv0541 09101416102D 17 15 0 0 1 0 999 V2000 0.1429 -1.3200 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.8574 -0.9075 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.5716 -0.9075 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.8574 -0.0825 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.5716 -0.0825 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 0.1429 0.3300 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 -1.2860 0.3300 0.0000 N 0 5 0 0 0 0 0 0 0 0 0 0 0.1429 1.1550 0.0000 N 0 5 0 0 0 0 0 0 0 0 0 0 4.0984 0.3572 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.6859 -0.3572 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.6859 1.0717 0.0000 O 0 5 0 0 0 0 0 0 0 0 0 0 4.9234 0.3572 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 4.0984 -1.0717 0.0000 O 0 5 0 0 0 0 0 0 0 0 0 0 2.8609 -0.3572 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 0.0000 -2.9700 0.0000 Pt 0 0 0 0 0 0 0 0 0 0 0 0 -0.5716 0.7425 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0 0.8574 0.7425 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0 2 1 1 0 0 0 0 3 1 1 0 0 0 0 4 2 1 0 0 0 0 5 3 1 0 0 0 0 6 4 1 0 0 0 0 6 5 1 0 0 0 0 5 7 1 1 0 0 0 6 8 1 6 0 0 0 10 9 1 0 0 0 0 11 9 1 0 0 0 0 12 9 2 0 0 0 0 13 10 1 0 0 0 0 14 10 2 0 0 0 0 5 16 1 6 0 0 0 6 17 1 1 0 0 0 M CHG 5 7 -1 8 -1 11 -1 13 -1 15 4 M END > T3D2674 > t3db > [Pt+4].[O-]C(=O)C([O-])=O.[H][C@@]1([NH-])CCCC[C@@]1([H])[NH-] > InChI=1S/C6H12N2.C2H2O4.Pt/c7-5-3-1-2-4-6(5)8;3-1(4)2(5)6;/h5-8H,1-4H2;(H,3,4)(H,5,6);/q-2;;+4/p-2 > DWAFYCQODLXJNR-UHFFFAOYSA-L > C8H12N2O4Pt > 395.276 > 395.044481331 > 2 > 27 > 13.080570547165479 > 1 > 2 > 0 > 0 > platinum(4+) ion (1R,2R)-cyclohexane-1,2-diaminide oxalate > 0.19 > -0.007973737333333194 > -1.99 > 0 > 1 > 2 > 9.985296744458648 > 40.46 > 30.636999999999997 > 1 > 1 > 4.60e+00 g/l > platinum(4+) ion (1R,2R)-cyclohexane-1,2-diaminide oxalate > 0 > T3D2674 > Oxaliplatin > 61825-94-3 > Eloxatin; L-OHP > Organic Compound; Drug; Antineoplastic Agent; Metabolite; Synthetic Compound $$$$